| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.01 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.01 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |